- Exchange: NASDAQ GM
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Specialty Pharmaceuticals
Pernix Therapeutics Holdings+ Add to Watchlist
PTX:US2.4800 USD 0.1300 5.53%
As of 15:23:20 ET on 12/10/2013.
Company Profile for Pernix Therapeutics Holdings (PTX)
Pernix Therapeutics Holdings, Inc. manufactures pharmaceuticals. The Company acquires, develops and markets medications for the pediatric market including treatments for dermatitis, statin-induced ubiquinone deficiency, deficiencies in active cultures due to diet and antibiotics, and upper respiratory conditions.
Pernix Therapeutics Holdings
Key Executives for Pernix Therapeutics Holdings (PTX)
|Michael C PearceChairman/President/CEO||Cooper C CollinsChief Strategic Officer|
|Brian T DorseySenior VP:Research & Dev||Tracy S CliffordVP:Accounting/Treasurer/Secy|